Henning Kelbæk

Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial

Thomas Engstrøm, Henning Kelbæk, Steffen Helqvist et al. · The Lancet · 2015 · 966 citations

Medicine, Cardiology, Internal Medicine +16

Comparison of Zotarolimus-Eluting and Everolimus-Eluting Coronary Stents

Patrick W. Serruys, Sigmund Silber, Scot Garg et al. · New England Journal of Medicine · 2010 · 664 citations · Full text

Medicine, Cardiology, Pharmacotherapy +17

Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

Jacob Lønborg, Niels Vejlstrup, Henning Kelbæk et al. · European Heart Journal · 2011 · 546 citations · Full text

Medicine, Cardiology, Pharmacology +16

Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

David Erlinge, Akiko Maehara, Ori Ben‐Yehuda et al. · The Lancet · 2021 · 477 citations · Full text

Medicine, Cardiology, Diagnostic Imaging +16

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

Frants Pedersen, Vitalij Butrymovich, Henning Kelbæk et al. · Journal of the American College of Cardiology · 2014 · 424 citations

Medicine, Cardiology, Internal Medicine +5